
Opinion|Videos|November 29, 2023
Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
Dr Sara M. Tolaney reviews the currently available treatment options for HER2-positive metastatic breast cancer and notes that many new HER2-targeting antibody-drug conjugates and bispecific antibodies are in development.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5




